These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20788711)

  • 1. Agranulocytosis Following Dapsone Therapy.
    McKenna WB; Chalmers AC
    Br Med J; 1958 Feb; 1(5066):324-5. PubMed ID: 20788711
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.
    Potočnjak I; Likić R; Šimić I; Juričić Nahal D; Čegec I; Ganoci L; Božina N
    Fundam Clin Pharmacol; 2017 Oct; 31(5):580-586. PubMed ID: 28322460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
    Satarasinghe RL; Jayawardana MA; De Silva GV; Murugathas S; Riyaaz AA; Wickrmasingha UD; Wijesinghe R
    Drug Metabol Drug Interact; 2009; 24(2-4):325-9. PubMed ID: 20408505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Agranulocytosis caused by dapsone. Apropos of 3 cases. Review of the literature].
    Liozon F; Fourgnaud-Gaillard S; Bordessoule D; Rousset H; Vidal E; Weinbreck P; Liozon E; Cransac M
    Ann Med Interne (Paris); 1988; 139(7):469-75. PubMed ID: 3072892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agranulocytosis caused by dapsone therapy for granuloma annulare.
    Potter MN; Yates P; Slade R; Kennedy CT
    J Am Acad Dermatol; 1989 Jan; 20(1):87-8. PubMed ID: 2643642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention.
    Coleman MD
    Toxicology; 2001 Apr; 162(1):53-60. PubMed ID: 11311458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agranulocytosis due to dapsone.
    Firkin FC; Mariani AF
    Med J Aust; 1977 Aug; 2(8):247-51. PubMed ID: 909500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone-induced haemolytic anaemia and agranulocytosis in a patient with normal glucose-6-phosphate-dehydrogenase activity.
    Figueiredo MS; Pinto BO; Zago MA
    Acta Haematol; 1989; 82(3):144-5. PubMed ID: 2510435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
    Bhat RM; Radhakrishnan K
    Lepr Rev; 2003 Jun; 74(2):167-70. PubMed ID: 12862258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of basophils in dapsone-induced agranulocytosis suggests a possible pathogenetic role for leucocyte peroxidases.
    Besser M; Vera J; Clark J; Chitnavis D; Beatty C; Vassiliou G
    Int J Lab Hematol; 2009 Apr; 31(2):245-7. PubMed ID: 19267812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agranulocytosis--a case report.
    Rahman J; Chowdhury SA; Wajed J
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):65-8. PubMed ID: 11508074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report].
    Hoffmann TK; von Schmiedeberg S; Wulferink M; Thier R; Bier H; Ruzicka T; Lehmann P
    Hautarzt; 2005 Jul; 56(7):673-7. PubMed ID: 15999287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).
    Booth F; Barker LC; Barton CJ; Naik RB
    Postgrad Med J; 1984 Aug; 60(706):566-7. PubMed ID: 6473241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1349-54. PubMed ID: 7945432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoleukemia during recovery from dapsone-induced agranulocytosis.
    Levine PH; Weintraub LW
    Ann Intern Med; 1968 May; 68(5):1060-5. PubMed ID: 5646810
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone-induced agranulocytosis in patients with Hansen's disease.
    Fernandes TRMO; Jesus BN; Barreto TT; Pereira AA
    An Bras Dermatol; 2017; 92(6):894-897. PubMed ID: 29364462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.